Kathy Giusti on urgency and oncology innovation at our company

This title was summarized by AI from the post below.

“Patients can’t wait” isn’t just something we say — it’s one of our values, and it sets the standard for how we work. Yesterday, we welcomed Kathy Giusti — founder of the Multiple Myeloma Research Foundation - MMRF, two-time cancer survivor, and author of Fatal to Fearless — for a conversation with our Chief Corporate Affairs Officer, Kym White. She showed how urgency becomes action when the right pieces align: “In a world where we now have #AI, where we have amazing science, and if you have a patient focus, you’ve got a triple whammy that is going to drive really good things to the market.” Kathy reminded us that urgency means staying focused on the people behind every discovery — and never losing sight of the promise our work represents. We’re now preparing to file two #oncology INDs: one for our MMAE payload neutralizer and another for our CAR-T therapy. Both are designed to make a difference for people living with cancer.  Want to learn more about our work in oncology? Watch our payload neutralizer in action: https://lnkd.in/eDMA5Twu #PatientsCantWait | #NowWeCan 

  • No alternative text description for this image

To view or add a comment, sign in

Explore content categories